Dimensional Fund Advisors LP Arrowhead Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 474,462 shares of ARWR stock, worth $19.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

474,462

Previous 366,711 29.38%

Holding current value

$19.6 Million

Previous $5.79 Million 182.43%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$14.71 - $34.49 $1.59 Million - $3.72 Million	107,751 Added 29.38%	474,462 $16.4 Million
Q2 2025 Aug 12, 2025	BUY	$9.99 - $16.97 $3.66 Million - $6.22 Million	366,711 New	366,711 $5.79 Million
Q4 2024 Feb 13, 2025	SELL	$17.7 - $26.34 $1.53 Million - $2.27 Million	-86,214 Reduced 70.74%	35,666 $670,000
Q3 2024 Nov 07, 2024	SELL	$19.36 - $29.54 $464,523 - $708,782	-23,994 Reduced 16.45%	121,880 $2.36 Million
Q2 2024 Aug 09, 2024	BUY	$21.87 - $28.24 $1.86 Million - $2.4 Million	84,867 Added 139.11%	145,874 $3.79 Million

Q1 2024 May 10, 2024	SELL	$27.21 - $39.48 $13.2 Million - $19.2 Million	-486,779 Reduced 88.86%	61,007 $1.74 Million
Q4 2023 Feb 07, 2024	SELL	$21.2 - $31.03 $2.97 Million - $4.35 Million	-140,125 Reduced 20.37%	547,786 $16.8 Million
Q3 2023 Nov 09, 2023	BUY	$26.2 - $36.08 $8.74 Million - $12 Million	333,516 Added 94.11%	687,911 $18.5 Million
Q2 2023 Aug 09, 2023	BUY	$25.16 - $41.38 $8.92 Million - $14.7 Million	354,395 New	354,395 $12.6 Million
Q3 2022 Nov 10, 2022	SELL	$29.63 - $48.31 $538,791 - $878,469	-18,184 Reduced 52.04%	16,759 $554,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $646,840 - $1.18 Million	-23,276 Reduced 39.98%	34,943 $1.23 Million
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $2.5 Million - $4.41 Million	-63,070 Reduced 52.0%	58,219 $2.68 Million
Q4 2021 Feb 09, 2022	SELL	$58.09 - $82.51 $2.14 Million - $3.04 Million	-36,801 Reduced 23.28%	121,289 $8.04 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $3.59 Million - $5.22 Million	-61,498 Reduced 28.01%	158,090 $9.87 Million
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $404,720 - $588,163	6,512 Added 3.06%	219,588 $18.2 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $1.18 Million - $1.74 Million	-19,224 Reduced 8.28%	213,076 $14.1 Million
Q4 2020 Feb 25, 2021	BUY	$43.82 - $85.37 $10.2 Million - $19.8 Million	232,300 New	232,300 $17.8 Million

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Arrowhead Pharmaceuticals, Inc. Transaction History